Open access
Open access
Powered by Google Translator Translator

#ACR19 – [Not Published Yet] Cohort Study: Half of People with Rheumatoid Arthritis Treated with Immune Checkpoint Inhibitors for Cancer Experience Flare, but Most Able to Continue Treatment

12 Nov, 2019 | 10:45h | UTC

Half of People with RA Treated with Immune Checkpoint Inhibitors for Cancer Experience Flare, but Most Able to Continue Treatment – American College of Rheumatology (free)

Abstract: Risk of Immunotherapy Related Toxicity in Patients with Rheumatoid Arthritis (free)

#ACR19 – Just Presented at the 2019 American College of Rheumatology Annual Meeting

 


Stay Updated in Your Specialty

Telegram Channels
Free

WhatsApp alerts 10-day free trial

No spam, just news.